MIMS Full Prescribing Update
New / Revised |
Product Name |
Section changed |
---|---|---|
New | Acnatac | |
New | Air Liquide Australia Limited Nitronox | |
New | Air Liquide Australia Limited Nitrous Oxide | |
New | Alendronate Plus D3-DRLA | |
New | AmoxyClav Generichealth | |
New | APO-Chloramphenicol | |
New | APO-Clomipramine | |
New | Arnuity Ellipta | |
New | BOC Gases Entonox | |
New | BOC Gases Nitrous Oxide | |
New | BOC Gases Oxygen | |
New | BOC Gases Refrigerated Liquid Oxygen | |
New | Coregas Medical Air | |
New | Equanox | |
New | Heliox28 | |
New | Hydromorphone JUNO/ JUNO-HP/ JUNO-XHP | |
New | Isosource Energy Fibre | |
New | Isosource Standard | |
New | Maxigesic IV | |
New | Morphine Sulfate Medsurge | |
New | NKCP | |
New | Noumed Rosuvastatin | |
New | Nyxoid | |
New | Ogivri | |
New | Olmesartan/Amlodipine APOTEX | |
New | Pemetrexed SUN | |
New | Sustagen Diabetic/ Diabetic Ready to Drink | |
New | Sustagen Optimum | |
New | Tenofovir Disoproxil/Emtricitabine/Efavirenz Mylan 300/200/600 | |
New | Tibolone Sandoz | |
Revised | Abraxane | Adverse Effects (Undesirable Effects), Fertility, Pregnancy and Lactation, Special Warnings and Precautions for Use |
Revised | Abyraz | Adverse Effects (Undesirable Effects) |
Revised | Acimax | Adverse Effects (Undesirable Effects) |
Revised | Aclasta | Special Warnings and Precautions for Use |
Revised | Actacode | Nature and Contents of Container |
Revised | Actair | TGA Date |
Revised | Adriamycin | Special Warnings and Precautions for Use |
Revised | Advate | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Qualitative and Quantitative Composition |
Revised | Albey Venom | TGA Date |
Revised | Alendronate Plus D3 APOTEX | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Special Warnings and Precautions for Use, Sponsor |
Revised | Amiloxyn | Adverse Effects (Undesirable Effects), Overdose, Special Warnings and Precautions for Use |
Revised | Amitriptyline Alphapharm | Adverse Effects (Undesirable Effects), Effects on Ability to Drive and Use Machines, Fertility, Pregnancy and Lactation, Interactions with Other Medicines and Other Forms of Interactions, Overdose, Qualitative and Quantitative Composition |
Revised | APO-Amoxycillin Powder for Suspension | List of Excipients |
Revised | APO-Baclofen | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Fertility, Pregnancy and Lactation, Overdose, Special Warnings and Precautions for Use |
Revised | APO-Bimatoprost | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | APO-Calcitriol | Dose and Method of Administration |
Revised | APO-Itraconazole | Adverse Effects (Undesirable Effects), Contraindications, Dose and Method of Administration, Fertility, Pregnancy and Lactation, Interactions with Other Medicines and Other Forms of Interactions, Therapeutic Indications |
Revised | APO-Mirtazapine | Adverse Effects (Undesirable Effects) |
Revised | APO-Montelukast | Adverse Effects (Undesirable Effects), Effects on Ability to Drive and Use Machines, Interactions with Other Medicines and Other Forms of Interactions |
Revised | APO-Mycophenolate Capsules | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Fertility, Pregnancy and Lactation, Interactions with Other Medicines and Other Forms of Interactions, List of Excipients, Special Warnings and Precautions for Use |
Revised | APO-Mycophenolate Tablets | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Effects on Ability to Drive and Use Machines, Fertility, Pregnancy and Lactation, Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | APO-Norfloxacin | Dose and Method of Administration, Special Warnings and Precautions for Use, Therapeutic Indications |
Revised | APO-Pantoprazole Heartburn Relief | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | APO-Pravastatin | Special Warnings and Precautions for Use |
Revised | APO-Valsartan | Interactions with Other Medicines and Other Forms of Interactions |
Revised | APO-Zolpidem | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Effects on Ability to Drive and Use Machines, Fertility, Pregnancy and Lactation, Interactions with Other Medicines and Other Forms of Interactions, Overdose, Special Warnings and Precautions for Use |
Revised | Aranesp | Adverse Effects (Undesirable Effects) |
Revised | Ativan | Fertility, Pregnancy and Lactation, Overdose, Special Warnings and Precautions for Use |
Revised | Avaxim | Interactions with Other Medicines and Other Forms of Interactions, Special Precautions for Storage |
Revised | Axit | Adverse Effects (Undesirable Effects) |
Revised | Azith | Interactions with Other Medicines and Other Forms of Interactions |
Revised | Azonaire Hayfever & Allergy Prevention & Relief Nasal Spray | Nature and Contents of Container |
Revised | Baxter Sodium Chloride and Glucose Intravenous Infusion BP | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | Belkyra | Adverse Effects (Undesirable Effects) |
Revised | BeneFIX | TGA Date |
Revised | BenPen | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use, Sponsor |
Revised | Berinert IV | Incompatibilities, Nature and Contents of Container, Product Name change, Shelf Life, Special Warnings and Precautions for Use |
Revised | Betahistine GH | Nature and Contents of Container, Physicochemical Properties |
Revised | Bexsero | Adverse Effects (Undesirable Effects) |
Revised | Biktarvy | Adverse Effects (Undesirable Effects) |
Revised | Biological Therapies Disodium Edetate 3g + Sodium Ascorbate 5g in 50mL Solution | Dose and Method of Administration |
Revised | Budenofalk Foam Enema | TGA Date |
Revised | Burinex | Sponsor |
Revised | Busulfan APOTEX | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Fertility, Pregnancy and Lactation, Incompatibilities, Interactions with Other Medicines and Other Forms of Interactions |
Revised | Carbaglu | Special Precautions for Storage, Sponsor |
Revised | Celexi | Adverse Effects (Undesirable Effects), Contraindications, Pharmacological Properties, Special Warnings and Precautions for Use |
Revised | Cephazolin Alphapharm | Deleted Presentation, Dose and Method of Administration, Nature and Contents of Container, Shelf Life |
Revised | C-Flox | Interactions with Other Medicines and Other Forms of Interactions |
Revised | Chemmart Mirtazapine | Adverse Effects (Undesirable Effects) |
Revised | Cialis | Nature and Contents of Container |
Revised | Ciproxin HC Ear Drops | Qualitative and Quantitative Composition |
Revised | Circadin | List of Excipients |
Revised | ClindaTech | Qualitative and Quantitative Composition |
Revised | Clonac | Adverse Effects (Undesirable Effects), Fertility, Pregnancy and Lactation, Interactions with Other Medicines and Other Forms of Interactions, List of Excipients, Nature and Contents of Container, Overdose, Pharmaceutical Form, Qualitative and Quantitative Composition, Special Warnings and Precautions for Use |
Revised | Cosentyx | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Pharmacological Properties |
Revised | Cosmegen | Pharmacological Properties |
Revised | Cotellic | TGA Date |
Revised | DBL Diazoxide Injection BP | TGA Date |
Revised | DBL Fentanyl Injection | Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | DBL Phenytoin Injection BP | Adverse Effects (Undesirable Effects), Fertility, Pregnancy and Lactation, Incompatibilities, Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | DBL Potassium Phosphate - Monobasic and Potassium Phosphate - Dibasic | Nature and Contents of Container, Product Name change, Sponsor |
Revised | DBL Promethazine Hydrochloride Injection BP | Contraindications, Special Warnings and Precautions for Use |
Revised | DBL Tobramycin Injection BP | Adverse Effects (Undesirable Effects), Contraindications, Fertility, Pregnancy and Lactation, Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | DermAid 1% Solution | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | DermAid 1% Spray | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | Descovy | Adverse Effects (Undesirable Effects), Interactions with Other Medicines and Other Forms of Interactions, Pharmacological Properties, Special Warnings and Precautions for Use |
Revised | Dimetapp PSE Cough, Cold & Flu Day & Night | Adverse Effects (Undesirable Effects), Fertility, Pregnancy and Lactation, Product Name change, Qualitative and Quantitative Composition, Special Warnings and Precautions for Use |
Revised | Dimetapp PSE Cough, Cold & Flu Day Relief | Adverse Effects (Undesirable Effects), Fertility, Pregnancy and Lactation, Product Name change, Qualitative and Quantitative Composition, Special Warnings and Precautions for Use |
Revised | Dimetapp PSE Cough, Cold & Flu Night Relief | Adverse Effects (Undesirable Effects), Fertility, Pregnancy and Lactation, Product Name change, Qualitative and Quantitative Composition, Special Warnings and Precautions for Use |
Revised | Dosulepin Mylan | Qualitative and Quantitative Composition |
Revised | Dothep | List of Excipients, Qualitative and Quantitative Composition |
Revised | Doxycycline Sandoz | Adverse Effects (Undesirable Effects), Fertility, Pregnancy and Lactation, Interactions with Other Medicines and Other Forms of Interactions, Nature and Contents of Container, New contraindication |
Revised | Doxylin | TGA Date |
Revised | Duloxetine Sandoz | Fertility, Pregnancy and Lactation |
Revised | Durotram XR | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | Enalapril Generic Health | Adverse Effects (Undesirable Effects), Effects on Ability to Drive and Use Machines, Fertility, Pregnancy and Lactation, Interactions with Other Medicines and Other Forms of Interactions, New contraindication, Overdose, Special Warnings and Precautions for Use |
Revised | Endep | Adverse Effects (Undesirable Effects), Interactions with Other Medicines and Other Forms of Interactions, Nature and Contents of Container, Overdose, Qualitative and Quantitative Composition |
Revised | Entecavir Mylan | TGA Date |
Revised | Epclusa | Adverse Effects (Undesirable Effects), Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | Epiduo Forte | Adverse Effects (Undesirable Effects), Fertility, Pregnancy and Lactation, Nature and Contents of Container, New contraindication |
Revised | Eraxis | TGA Date |
Revised | Ezetimibe/Simvastatin Sandoz | Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | Firazyr | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Nature and Contents of Container, New indication, Pharmacological Properties, Special Warnings and Precautions for Use |
Revised | Fludarabine Ebewe | Pharmacological Properties |
Revised | Flufeme | Adverse Effects (Undesirable Effects), Fertility, Pregnancy and Lactation, Interactions with Other Medicines and Other Forms of Interactions, Nature and Contents of Container, New contraindication, Product Name change, Special Warnings and Precautions for Use |
Revised | FonatPlus | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Special Warnings and Precautions for Use |
Revised | Frakas | Adverse Effects (Undesirable Effects), Fertility, Pregnancy and Lactation, Interactions with Other Medicines and Other Forms of Interactions, Nature and Contents of Container, New contraindication, Special Precautions for Storage |
Revised | Fraxiparine | Adverse Effects (Undesirable Effects), Pharmacological Properties, Shelf Life |
Revised | Fraxiparine Forte | Adverse Effects (Undesirable Effects) |
Revised | Genotropin, Genotropin GoQuick and Genotropin MiniQuick | Dose and Method of Administration, Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | Genvoya | Adverse Effects (Undesirable Effects) |
Revised | Glivec | Nature and Contents of Container, Special Warnings and Precautions for Use |
Revised | Glypressin Solution | Shelf Life |
Revised | Haldol Decanoate | Contraindications, Dose and Method of Administration, Fertility, Pregnancy and Lactation, Interactions with Other Medicines and Other Forms of Interactions, Pharmacological Properties, Special Warnings and Precautions for Use, Therapeutic Indications |
Revised | Harvoni | Special Warnings and Precautions for Use |
Revised | Herceptin SC | Adverse Effects (Undesirable Effects), Pharmacological Properties |
Revised | Hypnodorm | TGA Date |
Revised | Ibilex | TGA Date |
Revised | Imuran | Special Warnings and Precautions for Use |
Revised | Influvac Tetra | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Pharmacological Properties, Special Warnings and Precautions for Use, Therapeutic Indications |
Revised | Intralipid | Nature and Contents of Container |
Revised | Invanz | Adverse Effects, Precautions |
Revised | Inza | TGA Date |
Revised | Isordil | TGA Date |
Revised | Itracap | Adverse Effects (Undesirable Effects), Contraindications, Interactions with Other Medicines and Other Forms of Interactions, Overdose |
Revised | Jetrea | Sponsor |
Revised | Kabiven G11% | Description, Dosage and Administration, Presentation |
Revised | Kabiven G19% | Deleted Presentation |
Revised | Kalma | TGA Date |
Revised | Kaluril | TGA Date |
Revised | Keytruda | Adverse Effects (Undesirable Effects), Dose and Method of Administration, New indication, Pharmacological Properties, Special Warnings and Precautions for Use |
Revised | Kiovig | Adverse Effects (Undesirable Effects), Shelf Life |
Revised | Lanvis | Special Warnings and Precautions for Use |
Revised | Leflunomide Sandoz | TGA Date |
Revised | Lemtrada | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | Levemir | Interactions with Other Medicines and Other Forms of Interactions, Shelf Life, Special Warnings and Precautions for Use |
Revised | Losec Tablets | Adverse Effects (Undesirable Effects) |
Revised | Lynparza Capsules | Adverse Effects (Undesirable Effects), Qualitative and Quantitative Composition, Special Precautions for Storage |
Revised | Maviret | Special Warnings and Precautions for Use |
Revised | Maxor Heartburn Relief | Adverse Effects (Undesirable Effects) |
Revised | Methotrexate Injection BP | Interactions with Other Medicines and Other Forms of Interactions, Pharmacological Properties, Qualitative and Quantitative Composition |
Revised | Methylene Blue Injection | Qualitative and Quantitative Composition |
Revised | Metrogyl | List of Excipients, Qualitative and Quantitative Composition, Special Precautions for Storage |
Revised | Minirin Tablets | TGA Date |
Revised | Mirtazapine Sandoz | Adverse Effects (Undesirable Effects), Overdose, Special Warnings and Precautions for Use |
Revised | Mirtazapine Sandoz ODT | Adverse Effects (Undesirable Effects), Interactions with Other Medicines and Other Forms of Interactions, Overdose, Special Warnings and Precautions for Use |
Revised | Monace | Qualitative and Quantitative Composition |
Revised | Moxonidine GH | TGA Date |
Revised | Multibic | Deleted Presentation |
Revised | Neo-Mercazole | Adverse Effects (Undesirable Effects), Fertility, Pregnancy and Lactation, New contraindication, Special Warnings and Precautions for Use |
Revised | Nexium | Adverse Effects (Undesirable Effects) |
Revised | Noxicid Caps | Nature and Contents of Container, Qualitative and Quantitative Composition, Special Warnings and Precautions for Use |
Revised | Nplate | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Incompatibilities, New indication, Pharmacological Properties, Special Precautions for Storage, Special Warnings and Precautions for Use |
Revised | Numit 5% Cream | TGA Date |
Revised | Odefsey | Adverse Effects (Undesirable Effects), Fertility, Pregnancy and Lactation, Interactions with Other Medicines and Other Forms of Interactions, Overdose, Pharmacological Properties |
Revised | Olumiant | Shelf Life |
Revised | Omepral Tablets | Adverse Effects (Undesirable Effects) |
Revised | Omnitrope | TGA Date |
Revised | Opdivo | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | Optive Advanced | TGA Date |
Revised | Orgalutran | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | Osteovan | Special Warnings and Precautions for Use, Sponsor |
Revised | Oxycodone BNM | Adverse Effects (Undesirable Effects), Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | Paclitaxel Ebewe | TGA Date |
Revised | Panto | Adverse Effects (Undesirable Effects) |
Revised | Paracetamol IV Pfizer | Adverse Effects (Undesirable Effects), Interactions with Other Medicines and Other Forms of Interactions, Overdose, Special Warnings and Precautions for Use |
Revised | Pedea | Sponsor |
Revised | Petrus Bisacodyl Suppositories | Dosage and Administration, Indications, Precautions |
Revised | Phenasen | TGA Date |
Revised | Piramal Sevoflurane | Dose and Method of Administration, Effects on Ability to Drive and Use Machines, Fertility, Pregnancy and Lactation, Interactions with Other Medicines and Other Forms of Interactions, Nature and Contents of Container, Pharmacological Properties, Special Warnings and Precautions for Use |
Revised | Plidogrel | Adverse Effects (Undesirable Effects) |
Revised | Pomalyst | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Nature and Contents of Container, New indication, Pharmacological Properties, Shelf Life, Special Warnings and Precautions for Use |
Revised | Pradaxa | Adverse Effects (Undesirable Effects), Contraindications, Dose and Method of Administration, Interactions with Other Medicines and Other Forms of Interactions, List of Excipients, New contraindication, Pharmacological Properties, Special Warnings and Precautions for Use |
Revised | Pravastatin generichealth | Pharmaceutical Form, Qualitative and Quantitative Composition |
Revised | Presolol | Physicochemical Properties |
Revised | Primaxin | Adverse Effects, Precautions |
Revised | Pritor/Amlodipine | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Fertility, Pregnancy and Lactation, New contraindication, Overdose, Special Warnings and Precautions for Use |
Revised | Privigen | Qualitative and Quantitative Composition |
Revised | Prograf, Prograf XL | Nature and Contents of Container, Pharmaceutical Form, Qualitative and Quantitative Composition |
Revised | Puri-Nethol | Special Warnings and Precautions for Use |
Revised | Quinine Dihydrochloride 6% (Phebra) Sterile Concentrate | TGA Date |
Revised | Rapamune | Dose and Method of Administration, Special Precautions for Storage |
Revised | Rectinol | Sponsor |
Revised | Remifentanil-AFT | TGA Date |
Revised | Renflexis | Dose and Method of Administration |
Revised | Resolve Tinea Powder | Adverse Effects, Dosage and Administration, Indications, Precautions |
Revised | Resource Plus | Dosage and Administration, Indications, Precautions |
Revised | RiaSTAP | Effects on Ability to Drive and Use Machines, Nature and Contents of Container, Physicochemical Properties, Shelf Life, Special Precautions for Storage, Special Warnings and Precautions for Use |
Revised | Roxin | Dose and Method of Administration, Special Warnings and Precautions for Use, Therapeutic Indications |
Revised | Salpraz | Qualitative and Quantitative Composition |
Revised | Salpraz Heartburn Relief | Adverse Effects (Undesirable Effects) |
Revised | Segluromet | Pharmacological Properties, Special Warnings and Precautions for Use |
Revised | Simponi | Adverse Effects (Undesirable Effects), Pharmacological Properties |
Revised | Simvastatin Sandoz | Adverse Effects (Undesirable Effects), Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | SmofKabiven Electrolyte Free | Dose and Method of Administration, Incompatibilities, Nature and Contents of Container, Physicochemical Properties, Qualitative and Quantitative Composition, Shelf Life, Special Warnings and Precautions for Use |
Revised | Soliris | Adverse Effects (Undesirable Effects), Boxed Warnings, Dose and Method of Administration, Fertility, Pregnancy and Lactation, Special Warnings and Precautions for Use |
Revised | Soluvit N | Special Warnings and Precautions for Use |
Revised | Somac Heartburn Relief | Adverse Effects (Undesirable Effects) |
Revised | Somac Injection | Adverse Effects (Undesirable Effects) |
Revised | Somac Tablets and Granules | Adverse Effects (Undesirable Effects) |
Revised | Steglatro | Pharmacological Properties, Special Warnings and Precautions for Use |
Revised | Steglujan | Special Warnings and Precautions for Use |
Revised | Sustagen Hospital Formula Active | Product Name change |
Revised | Sustagen Sport | Description, Dosage and Administration, Indications, Name of Medicine, Presentation |
Revised | Symbicort Turbuhaler | Dose and Method of Administration, Pharmacological Properties, Special Warnings and Precautions for Use, Therapeutic Indications |
Revised | Symmetrel | Special Warnings and Precautions for Use |
Revised | Tacrolimus Sandoz | Adverse Effects (Undesirable Effects), Interactions with Other Medicines and Other Forms of Interactions |
Revised | Targin | TGA Date |
Revised | Tasigna | Special Warnings and Precautions for Use |
Revised | Tazopip | TGA Date |
Revised | Telmisartan/HCT Sandoz | Adverse Effects (Undesirable Effects), Pharmacological Properties, Special Warnings and Precautions for Use |
Revised | Temaze | Qualitative and Quantitative Composition |
Revised | Tenofovir GH | TGA Date |
Revised | Terry White Chemists Mirtazapine | Adverse Effects (Undesirable Effects) |
Revised | Terry White Chemists Zopiclone | Adverse Effects (Undesirable Effects), Effects on Ability to Drive and Use Machines, Fertility, Pregnancy and Lactation, Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | Tisseel VH S/D | Dose and Method of Administration, Nature and Contents of Container, Pharmacological Properties, Qualitative and Quantitative Composition |
Revised | Tixol | Fertility, Pregnancy and Lactation |
Revised | Tobrex Ophthalmic | Special Warnings and Precautions for Use |
Revised | Tranexamic Acid LU | Product Name change, Sponsor |
Revised | Trelegy Ellipta | Adverse Effects (Undesirable Effects), Fertility, Pregnancy and Lactation, Pharmacological Properties |
Revised | Twynsta | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Fertility, Pregnancy and Lactation, Interactions with Other Medicines and Other Forms of Interactions, New contraindication, Overdose, Special Warnings and Precautions for Use |
Revised | Ursosan | TGA Date |
Revised | Valganciclovir Mylan | Contraindications, Effects on Ability to Drive and Use Machines, Interactions with Other Medicines and Other Forms of Interactions, Pharmacological Properties, Special Warnings and Precautions for Use |
Revised | VasoKINOX | Special Precautions for Storage |
Revised | Voriconazole Sandoz | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | Zactin Tabs | Qualitative and Quantitative Composition |
Revised | Zerbaxa | Adverse Effects (Undesirable Effects), Pharmacological Properties, Special Warnings and Precautions for Use |
Revised | Zithromax | Fertility, Pregnancy and Lactation, Interactions with Other Medicines and Other Forms of Interactions, List of Excipients, Qualitative and Quantitative Composition |
Revised | Zithromax IV | Fertility, Pregnancy and Lactation, Interactions with Other Medicines and Other Forms of Interactions |
Revised | Zolfend IV | TGA Date |
Revised | Zyrtec | Adverse Effects (Undesirable Effects), Effects on Ability to Drive and Use Machines, Physicochemical Properties, Special Precautions for Storage |
Deleted | Acyclo-V | |
Deleted | Atelvia Once-a-Month | |
Deleted | Aylide | |
Deleted | Chemmart Amoxycillin and Clavulanic Acid 875 mg/125 mg | |
Deleted | Chemmart Candesartan | |
Deleted | Chemmart Candesartan HCTZ | |
Deleted | Chemmart Carvedilol | |
Deleted | Chemmart Olanzapine | |
Deleted | Chemmart Pioglitazone | |
Deleted | Fendex ER | |
Deleted | Fosinopril/HCT Actavis | |
Deleted | Lanzek and Lanzek Zydis | |
Deleted | Pregnyl | |
Deleted | Reladdin | |
Deleted | Terry White Chemists Amoxycillin and Clavulanic Acid Tablets | |
Deleted | Terry White Chemists Candesartan | |
Deleted | Terry White Chemists Candesartan HCTZ | |
Deleted | Terry White Chemists Olanzapine | |
Deleted | Terry White Chemists Pioglitazone | |
Deleted | Xydep | |
Deleted | Zerit |
Copyright © MIMS Australia Pty Ltd. All rights reserved.
MIMS Australia
Suite 302, Level 3, 53 Berry Street
North Sydney NSW 2060
Phone: 1800 800 629
info@mims.com.au
www.mims.com.au